DUSP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.589600E-01
Normal-vs-Stage2
5.707800E-01
Normal-vs-Stage3
5.302400E-01
Normal-vs-Stage4
5.015800E-01
Stage1-vs-Stage2
3.448100E-02
Stage1-vs-Stage3
1.159370E-01
Stage1-vs-Stage4
4.359000E-01
Stage2-vs-Stage3
1.802810E-01
Stage2-vs-Stage4
1.834640E-01
Stage3-vs-Stage4
4.650000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.545800E-01
Normal-vs-AfricanAmerican
6.684000E-01
Normal-vs-Asian
4.961600E-01
Caucasian-vs-AfricanAmerican
2.018400E-01
Caucasian-vs-Asian
3.042800E-01
AfricanAmerican-vs-Asian
2.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.533400E-01
Normal-vs-Female
5.562400E-01
Male-vs-Female
9.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.573000E-01
Normal-vs-Age(41-60Yrs)
5.899400E-01
Normal-vs-Age(61-80Yrs)
5.380600E-01
Normal-vs-Age(81-100Yrs)
5.775200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.195200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.518400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.903600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.887600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.983400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.797400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.420600E-01
Normal-vs-Daily Drinker
6.024000E-01
Normal-vs-Weekly Drinker
5.541600E-01
Normal-vs-Occasional Drinker
5.253800E-01
Normal-vs-Social Drinker
4.661400E-01
Non Drinker-vs-Daily Drinker
4.858000E-01
Non Drinker-vs-Weekly Drinker
9.102000E-01
Non Drinker-vs-Occasional Drinker
8.107000E-01
Non Drinker-vs-Social Drinker
1.494430E-01
Daily Drinker-vs-Weekly Drinker
6.592000E-01
Daily Drinker-vs-Occasional Drinker
4.222400E-01
Daily Drinker-vs-Social Drinker
7.678200E-02
Weekly Drinker-vs-Occasional Drinker
7.668800E-01
Weekly Drinker-vs-Social Drinker
2.773200E-01
Occasional Drinker-vs-Social Drinker
3.271200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.420200E-01
Normal-vs-Grade 2
9.664600E-01
Normal-vs-Grade 3
7.771800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.044200E-01
Grade 1-vs-Grade 3
8.433800E-01
Grade 1-vs-Grade 4
7.420200E-01
Grade 2-vs-Grade 3
1.412330E-02
Grade 2-vs-Grade 4
9.664600E-01
Grade 3-vs-Grade 4
7.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.634000E-01
Normal-vs-NonDiabetic
5.540400E-01
Diabetic-vs-NonDiabetic
8.819000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.508800E-01
Normal-vs-NoPancreatitis
5.536400E-01
Pancreatitis-vs-NoPancreatitis
2.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.320200E-01
Normal-vs-N1
5.703400E-01
N0-vs-N1
4.635200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.787400E-01
Normal-vs-TP53-NonMutant
4.699000E-01
TP53-Mutant-vs-TP53-NonMutant
9.016600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
